share_log

Maxim Group Initiates Coverage On Alzamend Neuro With Buy Rating, Announces Price Target of $1.5

Maxim Group Initiates Coverage On Alzamend Neuro With Buy Rating, Announces Price Target of $1.5

Maxim集团以买入评级开始对Alzamend Neuro进行报道,宣布目标价为1.5美元
Benzinga ·  2023/04/12 09:31

Maxim Group analyst Michael Okunewitch initiates coverage on Alzamend Neuro (NASDAQ:ALZN) with a Buy rating and announces Price Target of $1.5.

Maxim集团分析师迈克尔·奥库内维奇以买入评级开始对Alzamend Neuro(纳斯达克股票代码:ALZN)进行报道,并宣布目标价为1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发